Hims & Hers to stop offering compounded semaglutide pill after FDA crackdown

Core Viewpoint - Hims & Hers will cease offering the compounded semaglutide pill following FDA's announcement of potential action against the company regarding its $49 weight-loss pill [1] Company Summary - Hims & Hers is a telehealth provider that has been involved in offering a compounded version of semaglutide for weight loss [1] - The decision to stop offering the pill comes in response to regulatory scrutiny from the U.S. Food and Drug Administration [1]